id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2010-N-0316-0002,FDA,FDA-2010-N-0316,"Agency Information Collection Activities; Proposals, Submissions, and Approvals: Adverse Event Pilot Program for Medical Products",Notice,N-Notice,2010-12-07T05:00:00Z,2010,12,2010-12-07T05:00:00Z,2011-01-07T04:59:59Z,2010-12-07T16:43:53Z,2010-30583,0,0,0900006480bb0c2a
FDA-2010-N-0316-0001,FDA,FDA-2010-N-0316,"Agency Information Collection Activities; Proposals, Submissions, and Approvals: Adverse Event Pilot Program for Medical Products",Notice,N-Notice,2010-07-09T04:00:00Z,2010,7,2010-07-09T04:00:00Z,2010-09-08T03:59:59Z,2010-07-09T13:45:54Z,2010-16807,0,0,0900006480b15fa5